Premium members can generate a formatted export covering composition trends, protocol adherence, and AI co-pilot insights
The mechanism of action of GLP-1 agonists involves binding to GLP-1 receptors on pancreatic beta cells, which stimulates glucose-dependent insulin secretion
GLP-1 agonists are eliminated through the kidneys, making them suitable for patients with mild renal or hepatic impairment without the need for dose adjustments
(Eligibility and Benefits) Wegovy is used to treat obesity in adults with a body mass index (BMI) of 30 or higher (obese) or 27 or higher (overweight) who have at least one weight-related health condition, such as high blood pressure, type 2 diabetes, or high cholesterol
In addition, we examined Pearsons partial correlation coefficient for each pair of variables, and none revealed significant correlations